Imatinib Mesylate Therapy in Patients of Chronic Myeloid Leukemia with Philadelphia Chromosome Positive: An Experience from Eastern India

Imatinib inhibits constitutively active BCR-ABL tyrosine kinase of chronic myeloid leukemia (CML). In a long term study it was found superior to interferon alfa plus cytarabine for newly diagnosed CML in the chronic phase. However, till date there is no major study to evaluate eastern Indian CML pat...

Full description

Saved in:
Bibliographic Details
Main Authors: Mukhopadhyay, A., Dasgupta, S., Mukhopadhyay, S., Bose, C. K., Sarkar, S., Gharami, F., Koner, S., Basak, J., Roy, U. K.
Format: Artigo
Language:Inglês
Published: Springer-Verlag 2011
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3332275/
https://ncbi.nlm.nih.gov/pubmed/23730014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-011-0108-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items